Coming soon: news from HIV Glasgow 2018

Amelia Jones
Published: 25 October 2018

The International Congress on Drug Therapy in HIV Infection (HIV Glasgow) is taking place in Glasgow, UK, from 28 to 31 October. NAM is the official provider of online science news for the conference.

This year’s conference will feature research on:

  • The safety of pre-exposure prophylaxis (PrEP)
  • Dual therapy HIV treatment regimens
  • Treatment for heavily treatment-experienced people
  • Dolutegravir and neural tube defects.

For more information on the conference, visit the official conference website at and view the online scientific programme.

NAM will be publishing news online at and sending out a round-up of news in a summary bulletin in the week after the conference. The bulletin will be available in English, French, Spanish, Portuguese, Russian and Italian. Sign up here for the bulletin. You will receive this bulletin automatically if you already subscribe to our regular news bulletins.

Sharing knowledge, changing lives

NAM works to change lives by sharing information about HIV and you can help by sharing links to the research presented at the conferences. So please feel free to link to our news stories, bulletins and any other pages – in emails, newsletters and blogs or in other social media like Facebook and Twitter.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.